Text full multimedia monochrome

First time here?

Find out more about how The Lecture List works.

Coronavirus situation update

Our lecture organisers may or may not have had time to update their events with cancellation notices. Clearly social gatherings are to be avoided and that includes lectures. STAY AT HOME FOLKS, PLEASE.

Help!

Find out what you can do to keep The Lecture List online

An evening with investigative journalist Sonia Shah

Investigative journalist Sonia Shah uncovers evidence that big pharmaceutical companies have carried out drug trials in the developing world that cause serious illness and death.


nvestigative journalist Sonia Shah uncovers evidence that big pharmaceutical companies have carried out drug trials in the developing world that cause serious illness and death.

Experimental drugs trials can be risky even when all the safety guidelines are followed. But overseas clinical trials are often run with little concern for safety or ethics and take advantage of desperate patients. Many patients have died as a result.

The author of The Body Hunters: Testing news drugs on the World’s Poorest Patients, Sonia Shah will talk about some of the most shocking examples of global drug-testing practice. They range from drug addicts on HIV vaccine trials being denied access to clean needles and patients dying from well-known side effects to placebos rather than potentially life-saving drugs being administered to babies born to AIDS-infected mothers.

The event is organised in association with Centre for Investigative Journalism.


Speaker(s):

Ms Sonia Shah | talks

 

Date and Time:

6 November 2006 at 7:30 pm

Duration:

1 hour 30 minutes

 

Venue:

The Frontline Club
13 Norfolk Place
London
W2 1QJ
020 7479 8950
http://www.frontlineclub.com

More at The Frontline Club...

 

Tickets:

£5

Available from:

events@frontlineclub.com

Additional Information:

www.frontlineclub.com

Register to tell a friend about this lecture.

Comments

If you would like to comment about this lecture, please register here.



 

Any ad revenue is entirely reinvested into the Lecture List's operating fund